MXPA04004371A - Agente antipruritico. - Google Patents

Agente antipruritico.

Info

Publication number
MXPA04004371A
MXPA04004371A MXPA04004371A MXPA04004371A MXPA04004371A MX PA04004371 A MXPA04004371 A MX PA04004371A MX PA04004371 A MXPA04004371 A MX PA04004371A MX PA04004371 A MXPA04004371 A MX PA04004371A MX PA04004371 A MXPA04004371 A MX PA04004371A
Authority
MX
Mexico
Prior art keywords
derivative
antipruritic agent
halogeno
hydrate
treatments
Prior art date
Application number
MXPA04004371A
Other languages
English (en)
Inventor
Makoto Yagi
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of MXPA04004371A publication Critical patent/MXPA04004371A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)

Abstract

Un farmaco para la prevencion de o tratamientos para sintomas de comezon que contiene un ingrediente activo un derivado de prostaglandina representada por la formula [1]:Ver formula(en donde X1 y X2 son diferentes y cada uno representa hidrogeno, halogeno o hidroxi) una sal farmaceuticamente aceptable del derivado o un hidrato del derivado.
MXPA04004371A 2002-08-09 2003-08-07 Agente antipruritico. MXPA04004371A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002234011 2002-08-09
PCT/JP2003/010051 WO2004014394A1 (ja) 2002-08-09 2003-08-07 止痒剤

Publications (1)

Publication Number Publication Date
MXPA04004371A true MXPA04004371A (es) 2004-08-13

Family

ID=31711882

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04004371A MXPA04004371A (es) 2002-08-09 2003-08-07 Agente antipruritico.

Country Status (18)

Country Link
US (1) US7718701B2 (es)
EP (1) EP1527781B1 (es)
JP (1) JP3678366B2 (es)
KR (1) KR100904583B1 (es)
CN (1) CN100408039C (es)
AT (1) ATE401895T1 (es)
AU (1) AU2003254850B2 (es)
CA (1) CA2465103C (es)
DE (1) DE60322395D1 (es)
DK (1) DK1527781T3 (es)
ES (1) ES2309380T3 (es)
HK (1) HK1076391A1 (es)
MX (1) MXPA04004371A (es)
NO (1) NO20042053L (es)
PL (1) PL373819A1 (es)
PT (1) PT1527781E (es)
TW (1) TW200404053A (es)
WO (1) WO2004014394A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266880A1 (en) * 2002-02-22 2004-12-30 Fumie Sato Antipruritics
AU2003280977B2 (en) 2002-07-12 2008-10-23 Fumie Sato Prostaglandin derivatives
EP1527781B1 (en) 2002-08-09 2008-07-23 Taisho Pharmaceutical Co., Ltd Antipruritic agent
US7737182B2 (en) * 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
CA2597537A1 (en) * 2005-02-14 2006-08-17 Akihiko Kamiya Ointment
ES2402060T3 (es) 2005-10-03 2013-04-26 Nippon Shinyaku Co., Ltd. Derivado de quinazolina y producto farmacéutico
US20100016427A1 (en) * 2006-08-11 2010-01-21 Taishio Pharmaceutical Co., Ltd. External preparation comprising prostaglandin derivative
WO2009004873A1 (ja) 2007-06-29 2009-01-08 Taisho Pharmaceutical Co., Ltd. プロスタグランジン誘導体含有水性液剤

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3126924A1 (de) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
US4983629A (en) * 1983-07-08 1991-01-08 Schering Aktiengesellschaft 11-haloprostane derivatives, processes for their preparation and their use as medicinal agents
DE3325175A1 (de) * 1983-07-08 1985-01-17 Schering AG, 1000 Berlin und 4709 Bergkamen 11-halogen-prostanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3347128A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 9-halogen-(delta)(pfeil hoch)2(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
HU206084B (en) * 1987-07-17 1992-08-28 Schering Ag Process for producing 9-halogen-/z/-prostaglandin derivatives and pharmaceutical compositions comprising such active ingredient
US5891910A (en) * 1987-07-17 1999-04-06 Schering Aktiengesellschaft 9-halogen-(Z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents
US5591446A (en) * 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
US5252602A (en) 1991-10-11 1993-10-12 Rafeul Alam Effects of misoprostol on allergic responses
DE69327432T2 (de) * 1992-02-07 2000-05-18 Kaken Pharma Co Ltd Heilmittel für wunden und hämorrhoiden
CA2140853A1 (en) * 1992-07-24 1994-02-03 Takehiro Amano Prostaglandin derivatives
US5545666A (en) * 1992-10-20 1996-08-13 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivatives
US6124344A (en) * 1993-12-28 2000-09-26 Allergan Sales, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
JP3579448B2 (ja) * 1993-12-29 2004-10-20 大正製薬株式会社 プロスタグランジン誘導体、その塩およびその使用
JP3573482B2 (ja) * 1994-03-07 2004-10-06 大正製薬株式会社 プロスタグランジン誘導体およびその使用
JP3506485B2 (ja) * 1994-04-19 2004-03-15 大正製薬株式会社 プロスタグランジン誘導体
US5807892A (en) 1994-09-30 1998-09-15 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
AU3936495A (en) * 1994-11-30 1996-06-19 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivative
JPH0971539A (ja) 1995-09-08 1997-03-18 Mochida Pharmaceut Co Ltd 外用鎮痒剤
JPH09169638A (ja) 1995-10-18 1997-06-30 Sekisui Chem Co Ltd 皮膚疾患治療用外用剤
US5599838A (en) * 1996-02-23 1997-02-04 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivatives
JPH09286775A (ja) * 1996-04-24 1997-11-04 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
WO1997045114A1 (en) 1996-05-30 1997-12-04 Lysis Corporation The treatment of vascular disease with prostaglandins via a sustained-release dermal patch
CA2275663C (en) * 1996-12-23 2008-03-18 Robin Kenneth Stewart Phillips Pharmaceutical compositions comprising .alpha.-adrenergic agonists for the treatment of fecal incontinence
NO317155B1 (no) 1997-02-04 2004-08-30 Ono Pharmaceutical Co <omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater
JPH10316564A (ja) 1997-05-21 1998-12-02 Sekisui Chem Co Ltd 鎮痒鎮痛外用剤
JPH1180031A (ja) 1997-07-14 1999-03-23 Sekisui Chem Co Ltd 外用剤及び経皮又は経粘膜吸収性を増進する方法
JPH11199478A (ja) * 1998-01-05 1999-07-27 Hiroshi Nagoshi レチノイド並びにプロスタグランジンｄ▲２▼誘導体の抗炎症薬としての使用
EP1083168B1 (en) * 1998-05-25 2003-10-22 Taisho Pharmaceutical Co., Ltd Prostaglandin derivative
ATE295183T1 (de) 1998-06-03 2005-05-15 Shionogi & Co Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten
US6506789B2 (en) * 1998-06-03 2003-01-14 Shionogi & Co., Ltd. Methods for the treatment of itching comprising administering PGD2 receptor antagonist
TWI249520B (en) * 1998-07-15 2006-02-21 Ono Pharmaceutical Co 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
ES2264278T3 (es) 1998-11-23 2006-12-16 Proteome Sciences, Inc. Metodos y composiciones para el tratamiento.
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
JP2000273083A (ja) * 1999-03-19 2000-10-03 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
JP2001089443A (ja) * 1999-07-19 2001-04-03 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
US6740772B1 (en) * 1999-09-10 2004-05-25 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivatives
DE60008399T2 (de) 1999-09-14 2004-12-09 Merck Frosst Canada & Co, Kirkland Carbonsäuren und acylsulfonamide, solche verbindungen enthaltende zubereitungen und behandlungsmethoden
JP2001122786A (ja) * 1999-10-20 2001-05-08 Taisho Pharmaceut Co Ltd 睡眠誘発剤
JP2001151749A (ja) * 1999-11-24 2001-06-05 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
CA2389869A1 (en) * 1999-11-24 2001-05-31 Taisho Pharmaceutical Co., Ltd. Preparation for nasal administration
WO2001049661A1 (fr) * 2000-01-05 2001-07-12 Ono Pharmaceutical Co., Ltd. ALCOOLS 5-THIA-φ-(PHENYLE SUBSTITUES)- PROSTAGLANDINE E, PROCESSUS DE PREPARATION DE CES ALCOOLS ET PREPARATIONS PHARMACEUTIQUES CONTENANT CES ALCOOLS COMME PRINCIPE ACTIF.
JP2001220355A (ja) 2000-02-07 2001-08-14 Teijin Ltd ＰＰＡＲβ／δ及びγリガンドからなる肥満細胞活性化抑制剤
US6878522B2 (en) 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
EP1312601A4 (en) 2000-08-22 2005-09-21 Ono Pharmaceutical Co CARBOXYLENE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THEM AS AN ACTIVE SUBSTANCE
CA2419722A1 (en) * 2000-09-01 2003-02-21 Masaki Asada Benzoic acid derivatives and drugs containing the same as the active ingredient
WO2002045718A1 (en) 2000-12-08 2002-06-13 Institut Pasteur De Lille Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells
US20040266880A1 (en) * 2002-02-22 2004-12-30 Fumie Sato Antipruritics
KR20040083416A (ko) * 2002-02-22 2004-10-01 다이쇼 세이야꾸 가부시끼가이샤 지양제
US7737182B2 (en) * 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
EP1527781B1 (en) 2002-08-09 2008-07-23 Taisho Pharmaceutical Co., Ltd Antipruritic agent

Also Published As

Publication number Publication date
KR20050026375A (ko) 2005-03-15
PT1527781E (pt) 2008-08-12
TWI328574B (es) 2010-08-11
JPWO2004014394A1 (ja) 2005-12-02
CN1620297A (zh) 2005-05-25
PL373819A1 (en) 2005-09-19
US7718701B2 (en) 2010-05-18
EP1527781A4 (en) 2006-12-13
DK1527781T3 (da) 2008-11-17
US20050009917A1 (en) 2005-01-13
HK1076391A1 (en) 2006-01-20
NO20042053L (no) 2004-05-18
TW200404053A (en) 2004-03-16
CA2465103A1 (en) 2004-02-19
CN100408039C (zh) 2008-08-06
AU2003254850A1 (en) 2004-02-25
AU2003254850B2 (en) 2008-05-15
EP1527781B1 (en) 2008-07-23
ATE401895T1 (de) 2008-08-15
EP1527781A1 (en) 2005-05-04
WO2004014394A1 (ja) 2004-02-19
DE60322395D1 (de) 2008-09-04
KR100904583B1 (ko) 2009-06-25
JP3678366B2 (ja) 2005-08-03
CA2465103C (en) 2011-04-26
ES2309380T3 (es) 2008-12-16

Similar Documents

Publication Publication Date Title
MY140638A (en) New heterocyclic compounds, which are active as inhibitors of beta-lactamases
NZ512883A (en) 2-oxoquinoline compounds and medicinal uses thereof
BG105149A (en) Thiobenzimidazole derivatives
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
AU2002950217A0 (en) 8- Hydroxy Quinoline Derivatives
YU69902A (sh) Novi derivati piperazina
MXPA05010185A (es) Metodos para tratar o prevenir un estado inflamatorio o metabolico por inhibicion de jnk.
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
MXPA02012712A (es) N-ureidoheterocicloalquil-piperidinas como moduladores de la actividad del receptor de quimiocinas.
IL157254A0 (en) N-substituted nonaryl-heterocyclic nmda/mr2b antagonists
WO2006113552A3 (en) Cyanoarylamines
TW200740434A (en) A prophylactic and/or therapeutic agent for for sleep disorders
NO20052182L (no) Nye forbindelser
RS84904A (en) Combined use of antitumor indolopyrrolocarbazole derivative and other antitumor agent
AP2002002664A0 (en) Cyclohexylamine derivative as subtype selective NMDA receptor antagonists.
MXPA03010761A (es) Combinaciones farmaceuticas.
NZ333826A (en) Antithrombotic and antiatherogenic pharmaceutical composition including a thienopyridine derivative and an HMG-CoA-reductase inhibitor
MXPA02002452A (es) Agentes preventivos y terapeuticos para enfermedades de oftalmicas.
AU4249700A (en) Hydroxamic acid derivative
MX344556B (es) Agonista de subtipo de receptor 5-ht1a.
EP1192949A4 (en) PREVENTIVE OR THERAPEUTIC DRUGS FOR TREATING FIBROSIS AND CONTAINING CHYMASE INHIBITORS AS ACTIVE INGREDIENTS
MXPA04004371A (es) Agente antipruritico.
EP1757285A4 (en) PREVENTIVE AND / OR THERAPEUTIC AGENT FOR CHRONIC SINUSITIS
WO2005053702A3 (en) Anti-inflammatory agents
MXPA05011521A (es) Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.

Legal Events

Date Code Title Description
FG Grant or registration